CAPN10
Basic information
Region (hg38): 2:240586734-240617705
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (120 variants)
- not_provided (25 variants)
- CAPN10-related_disorder (16 variants)
- not_specified (1 variants)
- Diabetes_mellitus,_noninsulin-dependent,_1 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CAPN10 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000023083.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 15 | 20 | ||||
| missense | 113 | 12 | 131 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 2 | |||||
| splice donor/acceptor (+/-2bp) | 2 | |||||
| Total | 3 | 0 | 116 | 27 | 9 |
Highest pathogenic variant AF is 0.000008894922
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CAPN10 | protein_coding | protein_coding | ENST00000391984 | 12 | 30990 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 6.92e-13 | 0.620 | 125671 | 0 | 76 | 125747 | 0.000302 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.17 | 357 | 425 | 0.841 | 0.0000282 | 4261 |
| Missense in Polyphen | 123 | 152.26 | 0.80784 | 1682 | ||
| Synonymous | -0.697 | 207 | 195 | 1.06 | 0.0000137 | 1426 |
| Loss of Function | 1.56 | 24 | 33.8 | 0.710 | 0.00000163 | 334 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000479 | 0.000476 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000329 | 0.000326 |
| Finnish | 0.000791 | 0.000786 |
| European (Non-Finnish) | 0.000288 | 0.000273 |
| Middle Eastern | 0.000329 | 0.000326 |
| South Asian | 0.000169 | 0.000163 |
| Other | 0.000663 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction. May play a role in insulin-stimulated glucose uptake. {ECO:0000269|PubMed:17572128}.;
- Pathway
- Integrin-mediated Cell Adhesion;Extracellular matrix organization;Degradation of the extracellular matrix
(Consensus)
Recessive Scores
- pRec
- 0.211
Intolerance Scores
- loftool
- 0.111
- rvis_EVS
- -0.33
- rvis_percentile_EVS
- 30.92
Haploinsufficiency Scores
- pHI
- 0.0693
- hipred
- N
- hipred_score
- 0.379
- ghis
- 0.531
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.160
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Capn10
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); liver/biliary system phenotype; renal/urinary system phenotype; immune system phenotype;
Gene ontology
- Biological process
- proteolysis;cellular component disassembly involved in execution phase of apoptosis;actin cytoskeleton reorganization;positive regulation of insulin secretion;positive regulation of intracellular transport;cellular response to insulin stimulus;positive regulation of glucose import;type B pancreatic cell apoptotic process;positive regulation of type B pancreatic cell apoptotic process
- Cellular component
- cytoplasm;mitochondrion;cytosol;plasma membrane
- Molecular function
- SNARE binding;calcium-dependent cysteine-type endopeptidase activity;cytoskeletal protein binding